Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Author:

Motzer Robert J.1,Tannir Nizar M.1,McDermott David F.1,Arén Frontera Osvaldo1,Melichar Bohuslav1,Choueiri Toni K.1,Plimack Elizabeth R.1,Barthélémy Philippe1,Porta Camillo1,George Saby1,Powles Thomas1,Donskov Frede1,Neiman Victoria1,Kollmannsberger Christian K.1,Salman Pamela1,Gurney Howard1,Hawkins Robert1,Ravaud Alain1,Grimm Marc-Oliver1,Bracarda Sergio1,Barrios Carlos H.1,Tomita Yoshihiko1,Castellano Daniel1,Rini Brian I.1,Chen Allen C.1,Mekan Sabeen1,McHenry M. Brent1,Wind-Rotolo Megan1,Doan Justin1,Sharma Padmanee1,Hammers Hans J.1,Escudier Bernard1

Affiliation:

1. From Memorial Sloan Kettering Cancer Center, New York (R.J.M.), and Roswell Park Cancer Institute, Buffalo (S.G.) — both in New York; University of Texas M.D. Anderson Cancer Center, Houston (N.M.T., P. Sharma); Beth Israel Deaconess Medical Center, Dana–Farber/Harvard Cancer Center (D.F.M.), and Dana–Farber Cancer Institute, Brigham and Women’s Hospital, and Harvard Medical School (T.K.C.), Boston; Centro Internacional de Estudios Clínicos (O.A.F.) and Fundación Arturo López Pérez (P. Salman), Santiago,...

Funder

Bristol-Myers Squibb

Ono Pharmaceutical Company Limited

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3